Share This
table started by
bioventurist for the BioVenturist Base
There is no user-contributed description yet.
Add More Topics
Save this view to a base, or just for yourself.
874 BV: Venture Investor topics matching:
Filter this Collection
+
| x name | x image | x Investment Round | x article | ||
|---|---|---|---|---|---|
| x Investment round | x Amount raised | x Currency | |||
| x 21 Ventures | |||||
| x 3i |
|
Series D | 35,000,000 | US$ |
3i Group PLC (LSE: III) is a leading private equity firm. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
The company was formed in 1945, as the Industrial and Commercial Finance Corporation (ICFC), by the Bank...
|
| x 5AM Ventures | Series B | 8,000,000 | US$ | ||
| Series D | 12,000,000 | US$ | |||
| Series A | 25,000,000 | US$ | |||
| Series A | 33,000,000 | US$ | |||
| Series A | 10,000,000 | US$ | |||
| more ▼ | |||||
| x AIG Investments | |||||
| x ARCH Venture Partners |
|
Series C | 4,000,000 |
ARCH Venture Partners is a premier venture firm focused on disruptive technologies in the life sciences, physical sciences, and information technology.
|
|
| Series A | 15,000,000 | ||||
| Series A | 7,000,000 | US$ | |||
| 11,000,000 | US$ | ||||
| Series C | 10,000,000 | US$ | |||
| more ▼ | |||||
| x AXA Private Equity |
|
AXA Private Equity is a diversified private equity firm with $ 26 billion of assets managed or advised and with an international reach across Europe, North America and Asia. The firm provides investors with funds across the full range of private...
|
|||
| x Abbott Capital Management | |||||
| x Aberdare Ventures | Series E | 50,000,000 | US$ | ||
| Series D | 40,000,000 | US$ | |||
| x Abingworth Management | Series C | 60,000,000 | |||
| Series B | 18,000,000 | Euro | |||
| Series A | US$ | ||||
| Series A | 45,000,000 | US$ | |||
| Series B | 51,000,000 | US$ | |||
| x Acadia Woods Partners | |||||
| x Accelerator Corporation | |||||
| x Access Private Equity | 13,900,000 | ||||
| x Adage Capital Management L.P. | Series C | 60,000,000 | |||
| x Adams Street Partners | Series D | 30,000,000 | |||
| Series B | 93,000,000 | ||||
| Series D | 40,000,000 | US$ | |||
| Series A | 17,000,000 | US$ | |||
| x Advanced Technology Ventures |
|
Series C | 20,080,000 |
Founded in 1979, Advanced Technology Ventures (ATV) is a bi-coastal
venture capital firm with more than $1.4 billion in capital under
management. We work closely with entrepreneurial teams in several
technology markets, including communications,...
|
|
| Series C | 79,000,000 | ||||
| Series C | 60,000,000 | ||||
| Series D | 22,000,000 | US$ | |||
| 17,000,000 | US$ | ||||
| more ▼ | |||||
| x Advantage Capital Partners | |||||
| x Advent International |
|
Advent International is a global private equity firms focused on leveraged buyouts of middle market growth companies in Western and Central Europe, North America, Latin America and Asia. The firm focuses on international buyouts, strategic...
|
|||
| x Aescap Venture Management | Series B | 13,500,000 | Euro | ||
| Series B | 14,100,000 | Euro | |||
| x Affinity Capital Management | 1,500,000 | ||||
| Series B | 21,000,000 | ||||
| Series F | 20,500,000 | US$ | |||
| Series D | 10,200,000 | US$ | |||
| Series B | 22,000,000 | US$ | |||
| x AgeChem Venture Fund | |||||
| x Agilent Ventures | |||||
| x Aisling Capital | Series E | 30,000,000 | |||
| Series B | 15,000,000 | ||||
| x Alexandria Real Estate Equities, Inc. | Series A | 18,850,000 | US$ | ||
| Series A | 23,000,000 | US$ | |||
| x Alliance Technology Ventures L.P. | Series D | 25,000,000 | |||
| Series A | 10,400,000 | US$ | |||
| x Alloy Ventures |
|
Series C | 25,000,000 |
Alloy Ventures is an early-stage venture capital firm. Over the decades
of our history, our limited partners have entrusted us with over $1
billion in capital. We are currently investing out of our 5th fund a
$368 million limited partnership raised...
|
|
| Series D | 12,000,000 | US$ | |||
| Series B | 8,000,000 | US$ | |||
| Series C | 13,300,000 | US$ | |||
| x Alta Partners | Series B | 14,500,000 | |||
| Series A | 10,700,000 | ||||
| Series C | 45,000,000 | ||||
| Series C | 60,000,000 | ||||
| Series B | 18,500,000 | ||||
| more ▼ | |||||
| x Altitude Life Science Ventures | Series C | 4,000,000 | |||
| Series C | 10,000,000 | US$ | |||
| Series B | 17,000,000 | US$ | |||
| x Amberbrook | |||||
| x American Financial Group |
|
American Financial Group Incorporated (NYSE:Â AFG) is a holding company based in Cincinnati, Ohio whose primary business is insurance and investments. American Financial Group's purpose is to enable businesses and individuals to manage risk using...
|
|||
| x Amgen Ventures | Series C | 18,250,000 | |||
| x Amkey Ventures | |||||
| x Ampersand Ventures | |||||
| x Apple Tree Partners | Series D | 29,000,000 | US$ | ||
| x Arboretum Ventures | Series D | 19,200,000 | |||
| Series B | 7,500,000 | ||||
| Series D | 4,000,000 | US$ | |||
| Series C | 13,000,000 | US$ | |||
| Series B | 5,000,000 | US$ | |||
| x Arcturus Bioscience | |||||
| x Arnerich Massena & Associates Inc | |||||
| x Asset management company | Series C | 18,250,000 |
An asset management company is an investment management firm that invests the pooled funds of retail investors in securities in line with the stated investment objectives. For a fee, the investment company provides more diversification, liquidity,...
|
||
| 20,000,000 | US$ | ||||
| Series F | 20,500,000 | US$ | |||
| Series E | 16,000,000 | US$ | |||
| x Athenian Venture Partners | Series A | 25,000,000 | US$ | ||
| x Atlas Venture |
|
Series A | 8,000,000 |
We invest in technology and life sciences businesses in the U.S. and Europe through our offices in Boston, London, Munich, and Paris. We don’t just invest in companies. We partner
with them. Our team’s purpose is to apply our operational...
|
|
| Series A | 16,240,000 | ||||
| 22,000,000 | |||||
| Series B | 28,000,000 | ||||
| Series B | 14,000,000 | ||||
| more ▼ | |||||
| x Auriga Partners | Series A | 23,000,000 | US$ | ||
| x Austin Ventures |
|
Series E | 28,000,000 |
For more than twenty years, Austin Ventures has successfully
partnered with visionary entrepreneurs and startup executives to build
category-defining technology companies. We focus on seed and rapid
growth opportunities in: Our
venture capital team...
|
|
| x BA Venture Partners | |||||
| x BB Biotech Ventures | Series A | 16,240,000 | |||
| Series C | 15,000,000 | ||||
| 25,000,000 | US$ | ||||
| Series A | 21,000,000 | US$ | |||
| x BBT Fund L.P. | Series C | 4,000,000 | |||
| Series E | 84,000,000 | ||||
| Series D | 35,000,000 | US$ | |||
| Series C | 10,000,000 | US$ | |||
| x BDC Venture Capital | Series C | 45,000,000 | |||
| Series A | 11,000,000 | ||||
| Series B | 19,000,000 | ||||
| Series C | 12,000,000 | ||||
| 5,000,000 | Canadian dollar | ||||
| more ▼ | |||||
| x BTF B.V. | |||||
| x BTG PLC | |||||
| x Bain Capital Ventures | Series A | 15,000,000 | |||
| x Baird Venture Partners | Series A | 21,000,000 | US$ | ||
| Series D | 4,000,000 | US$ | |||
| Series C | 13,000,000 | US$ | |||
| Series B | 5,000,000 | US$ | |||
| x Baker Brothers | Series F | 9,200,000 | US$ | ||
| 30,000,000 | US$ | ||||
| 27,000,000 | US$ | ||||
| x Baltic Sea Foundation | |||||
| x Battelle Ventures | Series B | 30,000,000 | |||
| Series A | 3,000,000 | ||||
| x Battery Ventures L.P |
|
Founded in 1983, Battery Ventures is a leading venture capital firm
focused on investing in technology companies at all stages of growth,
from seed to later stage and tech buyouts. Battery leverages its
people, expertise, and capital to actively...
|
|||
| x Bay City Capital | Series B | 30,000,000 | |||
| Series A | 18,850,000 | US$ | |||
| Series E | 50,000,000 | US$ | |||
| x Ben Franklin Technology Partners | |||||
| x Bessemer Venture Partners |
|
Series A | 20,000,000 |
Bessemer Venture Partners is a private venture capital firm with offices in Silicon Valley, New York, Massachusetts, Israel, and India.
Bessemer Venture Partners is the longest-standing venture capital practice in the United States. Between 1911 and...
|
|
| x Bio Fund Management | |||||
| x BioAdvance Ventures | Series B | 30,000,000 | |||
| 550,000 | US$ | ||||
| x BioAsia Investments | |||||
| x BioMed Venture Partners | Series A | 16,240,000 | |||
